Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1060500759
rs1060500759
RET
T 0.700 CausalMutation CLINVAR

dbSNP: rs377767412
rs377767412
RET
A 0.700 GeneticVariation CLINVAR

dbSNP: rs77939446
rs77939446
RET
T 0.700 GeneticVariation CLINVAR

dbSNP: rs75996173
rs75996173
RET
A 0.730 CausalMutation CLINVAR Beyond generic occurrence screening. 2008030

1991
dbSNP: rs75996173
rs75996173
RET
A 0.730 CausalMutation CLINVAR Early treatment of hereditary medullary thyroid carcinoma after attribution of multiple endocrine neoplasia type 2 gene carrier status by screening for ret gene mutations. 7491519

1995
dbSNP: rs377767408
rs377767408
RET
CGTGC 0.700 CausalMutation CLINVAR The RET proto-oncogene and cancer. 7595167

1995
dbSNP: rs75076352
rs75076352
RET
C 0.710 CausalMutation CLINVAR From medical history and biochemical tests to presymptomatic treatment in a large MEN 2A family. 7595171

1995
dbSNP: rs79781594
rs79781594
RET
A 0.710 CausalMutation CLINVAR The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. 7608256

1995
dbSNP: rs77316810
rs77316810
RET
C 0.720 CausalMutation CLINVAR Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. 7633441

1995
dbSNP: rs77939446
rs77939446
RET
A 0.700 CausalMutation CLINVAR Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. 7633441

1995
dbSNP: rs79781594
rs79781594
RET
T 0.710 CausalMutation CLINVAR Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2. 7670926

1995
dbSNP: rs76262710
rs76262710
RET
A 0.720 CausalMutation CLINVAR Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. 7716719

1995
dbSNP: rs79658334
rs79658334
RET
T 0.720 CausalMutation CLINVAR RET mutations in exons 13 and 14 of FMTC patients. 7784092

1995
dbSNP: rs78014899
rs78014899
RET
C 0.700 CausalMutation CLINVAR RET mutations in exons 13 and 14 of FMTC patients. 7784092

1995
dbSNP: rs75996173
rs75996173
RET
A 0.730 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs76262710
rs76262710
RET
G 0.720 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs76262710
rs76262710
RET
A 0.720 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs76262710
rs76262710
RET
C 0.720 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs75076352
rs75076352
RET
G 0.710 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs75076352
rs75076352
RET
C 0.710 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs79781594
rs79781594
RET
A 0.710 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs79781594
rs79781594
RET
C 0.710 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995
dbSNP: rs76262710
rs76262710
RET
G 0.720 CausalMutation CLINVAR A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families. 7835899

1994
dbSNP: rs78014899
rs78014899
RET
C 0.700 CausalMutation CLINVAR A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. 7845675

1995
dbSNP: rs77316810
rs77316810
RET
A 0.720 CausalMutation CLINVAR RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. 7849720

1994